• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • Investors
  • News / Events
  • Press Releases
Navigation
  • Overview
  • News / Events
    • Press Releases
    • Events
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • Corporate Governance
  • SEDAR
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update

May 18, 2022

Ceapro Inc. to Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids

May 13, 2022

Ceapro Inc. Announces Publication of Results for PGX-Processed Alginates in the Journal of CO2 Utilization

May 11, 2022

Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors

April 19, 2022

Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

April 13, 2022

Ceapro Signs Exclusive Long-Term Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise

March 10, 2022

Ceapro Bolsters Board of Directors with Appointment of Top Executive from Global Pharmaceutical Industry

March 2, 2022

Ceapro Inc. to Present at the Virtual Investor 2022 Top Picks Conference

January 20, 2022

RSS
  • « Previous
  • 1
  • 2

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap